Table 1.
Recent trend in mortality from pleural mesotheliomaa in men.
| Country (code) | Period MRb (no.c) (deaths/million/year) | APCd [%/year (95% CI)] | Trende | Male populationf (million) |
|---|---|---|---|---|
| Asia | ||||
| Israel (ISR) | 5.5 (5) | 6.6 (−14.9 to 33.4) | ↔ | 3.1 |
| Japan (JPN) | 4.8 (9) | 3.9 (2.6 to 5.2) | ↑** | 61.4 |
| Eastern Europe and Southern Europe | ||||
| Croatia (HRV) | 8.8 (9) | 11.0 (2.7 to 20.0) | ↑** | 2.2 |
| Czech Republic (CZE) | 3.2 (9) | 6.3 (−1.7 to 15.0) | ↔ | 5.0 |
| Hungary (HUN) | 2.5 (8) | 11.0 (3.3 to 19.3) | ↑** | 4.9 |
| Poland (POL) | 2.0 (6) | 5.2 (−5.2 to 16.7) | ↔ | 18.7 |
| Romania (ROU) | 1.9 (6) | 1.2 (−11.2 to 15.3) | ↔ | 10.9 |
| Spain (ESP) | 5.7 (6) | 0.7 (−6.6 to 8.7) | ↔ | 19.8 |
| Northern Europe and Western Europe | ||||
| Austria (AUT) | 7.8 (4) | −5.9 (−20.9 to 12.0) | ↔ | 3.9 |
| Denmark (DNK) | 12.9 (6) | 4.6 (−6.5 to 16.9) | ↔ | 2.6 |
| Finland (FIN) | 12.6 (9) | −0.3 (−3.9 to 3.6) | ↔ | 2.5 |
| France (FRA) | 12.7 (4) | −1.0 (−14.7 to 14.9) | ↔ | 28.7 |
| Germany (DEU) | 12.0 (7) | 3.3 (−0.8 to 7.6) | ↑* | 40.1 |
| Iceland (ISL) | 10.1 (7) | −1.4 (−28.8 to 36.5) | ↔ | 0.1 |
| Lithuania (LTU) | 2.0 (5) | 12.3 (−34.3 to 92.1) | ↔ | 1.6 |
| Luxembourg (LUX) | 12.7 (7) | 5.4 (−11.0 to 24.8) | ↔ | 0.2 |
| Netherlands (NLD) | 30.0 (9) | 0.0 (−1.5 to 1.6) | ↔ | 7.9 |
| Norway (NOR) | 12.7 (9) | −2.7 (−7.5 to 2.3) | ↔ | 2.2 |
| Sweden (SWE) | 12.8 (6) | 3.5 (−2.0 to 9.2) | ↔ | 4.4 |
| United Kingdom (GBR) | 31.1 (4) | 0.5 (−4.0 to 5.3) | ↔ | 29.1 |
| Americas excluding South America | ||||
| Canada (CAN) | 10.3 (4) | 5.6 (−7.4 to 20.4) | ↔ | 15.1 |
| Cuba (CUB) | 0.6 (4) | 5.2 (−36.1 to 73.2) | ↔ | 5.6 |
| Mexico (MEX) | 2.2 (6) | 2.9 (−7.2 to 14.2) | ↔ | 49.4 |
| United States of America (USA) | 9.0 (4) | 0.8 (−2.4 to 4.1) | ↔ | 135.1 |
| South America | ||||
| Argentina (ARG) | 2.5 (7) | 8.9 (3.3 to 14.7) | ↑** | 18.6 |
| Brazil (BRA) | 0.5 (6) | 9.0 (0.1 to 18.7) | ↑** | 87.3 |
| Chile (CHL) | 3.1 (7) | 3.3 (−8.1 to 16.2) | ↔ | 7.5 |
| Ecuador (ECU) | 0.5 (4) | 16.4 (−37.5 to 116.7) | ↔ | 6.3 |
| Uruguay (URY) | 2.3 (5) | 13.6 (−43.7 to 129.2) | ↔ | 1.6 |
| Oceania | ||||
| Australia (AUS) | 25.5 (6) | 4.6 (−0.6 to 10.1) | ↑* | 9.5 |
| New Zealand (NZL) | 20.5 (4) | 10.4 (−10.3 to 35.7) | ↔ | 1.9 |
a
See “Materials and Methods” for our definition of mesothelioma.
b
Period MR from 1996 to 2005, age-adjusted to the world population of 2000.
c
Number of years with available data.
d
APC, together with its 95% CI and p-values, were calculated with Joinpoint software.
e
Trend: ↑ when APC > 0 (p < 0.10); ↓ when APC < 0 (p < 0.10); ↔ when p > 0.10 for APC.
f
Average of male national population from 1996 to 2005.
*
Marginally significant (0.05 < p < 0.10).
**
Statistically significant (p < 0.05).